Review of preclinical studies on treatment of mucositis and associated pain

Journal of Dental Research

Volumn 93, Issue 9, 2014, Pages 868-875

  Viet, C T ^a   Corby, P M ^a   Akinwande, A ^a   Schmidt, B L ^a  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

cancer complications; cancer symptoms; mucositis models; mucositis treatment; oral pain; stomatitis

Indexed keywords

ANALGESIC AGENT;

ANIMAL; CANCER COMPLICATIONS; CANCER SYMPTOMS; DISEASE MODEL; DRUG SCREENING; HEAD AND NECK TUMOR; HUMAN; MOUTH PAIN; MUCOSITIS MODELS; MUCOSITIS TREATMENT; NEURALGIA; PAIN; PAIN RECEPTOR; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STOMATITIS;

CANCER COMPLICATIONS; CANCER SYMPTOMS; MUCOSITIS MODELS; MUCOSITIS TREATMENT; ORAL PAIN; STOMATITIS;

ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HEAD AND NECK NEOPLASMS; HUMANS; NEURALGIA; NOCICEPTORS; PAIN; STOMATITIS;

EID: 84908024965     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514540174     Document Type: Review

References (61)

1. Alessandri-Haber N, Dina OA, Chen X, Levine JD. TRPC1 and TRPC6 channels cooperate with TRPV4 to mediate mechanical hyperalgesia and nociceptor sensitization. J Neurosci. 2009 ; 29: 6217-6228
2. Alterovitz G, Tuthill C, Rios I, Modelska K, Sonis S. Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-D-glutamyl-L-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis. Oral Oncol. 2011 ; 47: 951-955
3. Alvarez E, Fey EG, Valax P, Yim Z, Peterson JD, Mesri M, et al. Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis. Clin Cancer Res. 2003 ; 9: 3454-3461
4. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007 ; 7: 11
5. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009 ; 139: 267-284
6. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T, et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes. 1997 ; 46: 1481-1490
7. Bodiga VL, Bodiga S, Surampudi S, Boindala S, Putcha U, Nagalla B, et al. Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar/NIN rats. Nutrition. 2012 ; 28: 572-580
8. Booth D, Haley JD, Bruskin AM, Potten CS. Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer. 2000 ; 86: 53-59
9. Borges L, Rex KL, Chen JN, Wei P, Kaufman S, Scully S, et al. A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis. Int J Radiat Oncol Biol Phys. 2006 ; 66: 254-262
10. Bowen JM, Gibson RJ, Keefe DM. Animal models of mucositis: implications for therapy. J Support Oncol. 2011 ; 9: 161-168
11. Brake R, Starnes C, Lu J, Chen D, Yang S, Radinsky R, et al. Effects of palifermin on antitumor activity of chemotherapeutic and biological agents in human head and neck and colorectal carcinoma xenograft models. Mol Cancer Res. 2008 ; 6: 1337-1346
12. Chichorro JG, Zampronio AR, Cabrini DA, Franco CR, Rae GA. Mechanisms operated by endothelin ETA and ETB receptors in the trigeminal ganglion contribute to orofacial thermal hyperalgesia induced by infraorbital nerve constriction in rats. Neuropeptides. 2009 ; 43: 133-142
13. Chichorro JG, Fiuza CR, Bressan E, Claudino RF, Leite DF, Rae GA. Endothelins as pronociceptive mediators of the rat trigeminal system: role of ETA and ETB receptors. Brain Res. 2010 ; 1345: 73-83
14. Colburn RW1, Lubin ML, Stone DJ, Wang Y, Lawrence D, D'Andrea MR, et al. Attenuated cold sensitivity in TRPM8 null mice. Neuron. 2007 ; 54: 379-386
15. Cotrim AP, Yoshikawa M, Sunshine AN, Zheng C, Sowers AL, Thetford AD, et al. Pharmacological protection from radiation +/- cisplatin-induced oral mucositis. Int J Radiat Oncol Biol Phys. 2012 ; 83: 1284-1290
16. Dolan JC, Lam DK, Achdjian SH, Schmidt BL. The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain. J Neurosci Methods. 2010 ; 187: 207-215
17. Dorr W, Kummermehr J. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother Oncol. 1990 ; 17: 249-259
18. Dorr W, Bassler S, Reichel S, Spekl K. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice. Int J Radiat Oncol Biol Phys. 2005 ; 62: 881-887
19. Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL. Management of pain in cancer patients with oral mucositis: follow-up of multiple doses of doxepin oral rinse. J Pain Symptom Manage. 2007 ; 33: 111-114
20. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012 ; 62: 400-422
21. Fall-Dickson JM, Ramsay ES, Castro K, Woltz P, Sportes C. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation. Clin Therapeutics. 2007 ; 29: 2547-2561
22. Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 1998 ; 58: 933-939
23. Finch PW, Rubin JS. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res. 2004 ; 91: 69-136
24. Foncuberta MC, Cagnoni PJ, Brandts CH, Mandanas R, Fields K, Derigs HG, et al. Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors. J Immunother. 2001 ; 24: 384-388
25. Fujisawa K, Miyamoto Y, Nagayama M. Basic fibroblast growth factor and epidermal growth factor reverse impaired ulcer healing of the rabbit oral mucosa. J Oral Pathol Med. 2003 ; 32: 358-366
26. Gris P, Gauthier J, Cheng P, Gibson DG, Gris D, Laur O, et al. A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol Pain. 2010 ; 6: 33
27. Haas HS, Linecker A, Pfragner R, Sadjak A. Peripheral glutamate signaling in head and neck areas. Head Neck. 2010 ; 32: 1554-1572
28. Hamstra DA, Eisbruch A, Naidu MU, Ramana GV, Sunkara P, Campbell KC, et al. Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer. Clin Cancer Res. 2010 ; 16: 2666-2676
29. Hwang D, Popat R, Bragdon C, O'Donnell KE, Sonis ST. Effects of ceramide inhibition on experimental radiation-induced oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 ; 100: 321-329
30. Kim KI, Kim JW, Lee HJ, Kim BS, Bang SM, Kim I, et al. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation. Am J Hematol. 2013 ; 88: 107-112
31. Kramer PR, Kerins CA, Schneiderman E, Bellinger LL. Measuring persistent temporomandibular joint nociception in rats and two mice strains. Physiol Behav. 2010 ; 99: 669-678
32. Lalla RV, Gordon GB, Schubert M, Silverman S, Hutten M, Sonis ST, et al. A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Support Care Cancer. 2011 ; 20: 1797-1804
33. Lee SW, Jung KI, Kim YW, Jung HD, Kim HS, Hong JP. Effect of epidermal growth factor against radiotherapy-induced oral mucositis in rats. Int J Radiat Oncol Biol Phys. 2007 ; 67: 1172-1178
34. Majumdar S, Grinnell S, Le Rouzic V, Burgman M, Polikar L, Ansonoff M, et al. Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects. Proc Natl Acad Sci USA. 2011 ; 108: 19778-19783
35. Malik IA, Moid I, Haq S, Sabih M. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis. J Pain Symptom Manage. 1997 ; 14: 82-87
36. Mogil JS. Animal models of pain: progress and challenges. Nat Rev Neurosci. 2009 ; 10: 283-294
37. Moore C, Cevikbas F, Pasolli HA, Chen Y, Kong W, Kempkes C, et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc Natl Acad Sci USA. 2013 ; 110: E3225-3234
38. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007 ; 87: 165-217
39. Nolan TA, Hester J, Bokrand-Donatelli Y, Caudle RM, Neubert JK. Adaptation of a novel operant orofacial testing system to characterize both mechanical and thermal pain. Behav Brain Res. 2011 ; 217: 477-480
40. Oertel BG, Kettner M, Scholich K, Renne C, Roskam B, Geisslinger G, et al. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem. 2009 ; 284: 6530-6535
41. Pickering V, Jordan RC, Schmidt BL. Elevated salivary endothelin levels in oral cancer patients - a pilot study. Oral Oncol. 2007 ; 43: 37-41
42. Quang PN, Schmidt BL. Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice. J Pain. 2010a ; 11: 663-671
43. Quang PN, Schmidt BL. Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice. Pain. 2010b ; 149: 254-262
44. Ro JY. Bite force measurement in awake rats: a behavioral model for persistent orofacial muscle pain and hyperalgesia. J Orofac Pain. 2005 ; 19: 159-167
45. Ryu SH, Kang KM, Moon SY, Chai GY, Hong JP, Cho KO, et al. Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis. J Radiation Res. 2010 ; 51: 595-601
46. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, pathogenesis and prophylaxis of mucositis. Head Neck. 2003 ; 25: 1057-1070
47. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, et al. Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet. 2009 ; 18: 1037-1051
48. Sonis ST. Oral mucositis in cancer therapy. J Support Oncol. 2004 ; 2 (6). 3S - 8S
49. Sonis ST. Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core Evid. 2010 ; 4: 199-205
50. Sonis ST. Oral mucositis in head and neck cancer. Am Soc Clin Oncol Educ Book. 2013 2013 ;: 236-240
51. Sonis ST, Tracey C, Shklar G, Jenson J, Florine D. An animal model for mucositis induced by cancer chemotherapy. Oral Surg Oral Med Oral Pathol. 1990 ; 69: 437-443
52. Uddman R, Tajti J, Cardell LO, Sundler F, Uddman E, Edvinsson L. Endothelin ETA and ETB receptor expression in the human trigeminal ganglion. Neuro Endocrinol Lett. 2006 ; 27: 345-349
53. Vilela-Goulart M, Teixeira RT, Rangel DC, Niccoli-Filho W, Gomes MF. Homogenous amniotic membrane as a biological dressing for oral mucositis in rats: histomorphometric analysis. Arch Oral Biol. 2008 ; 53: 1163-1171
54. Vuyyuri SB, Hamstra DA, Khanna D, Hamilton CA, Markwart SM, Campbell KC, et al. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis. Clin Cancer Res. 2008 ; 14: 2161-2170
55. Watanabe T, Ishihara M, Matsuura K, Mizuta K, Itoh Y. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer. Int J Cancer. 2010 ; 127: 1984-1990
56. Watkins B, Pouliot K, Fey E, Tuthill C, Sonis S. Attenuation of radiation- and chemoradiation-induced mucositis using gamma-D-glutamyl-L-tryptophan (SCV-07). Oral Dis. 2010 ; 16: 655-660
57. Wolfe D, Mata M, Fink DJ. A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther. 2009 ; 16: 455-460
58. Wu X, Chen P, Sonis ST, Lingen MW, Berger A, Toback FG. A novel peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis. Int J Radiat Oncol Biol Phys. 2012 ; 83: e409 - e415
59. Wymenga AN, van der Graaf WT, Hofstra LS, Spijkervet FK, Timens W, Timmer-Bosscha H, et al. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. Clin Cancer Res. 1999 ; 5: 1363-1368
60. Yamamoto T, Ono K, Hitomi S, Harano N, Sago T, Yoshida M, et al. Endothelin receptor-mediated responses in trigeminal ganglion neurons. J Dent Res. 2013 ; 92: 335-339
61. Ye Y, Dang D, Zhang J, Viet CT, Lam DK, Dolan JC, et al. Nerve growth factor links oral cancer progression, pain, and cachexia. Mol Cancer Ther. 2011 ; 10: 1667-1676